CENTRAL-NERVOUS-SYSTEM METASTASES IN PATIENTS WITH OVARIAN-CARCINOMA - A REPORT OF 23 CASES AND A LITERATURE-REVIEW

被引:67
作者
CORMIO, G
MANEO, A
PARMA, G
PITTELLI, MR
MICELI, MD
BONAZZI, C
机构
[1] UNIV MILAN, OSPED S GERARDO, IST SCI BIOMED, DEPT CLIN OSTET & GINECOL 3, I-20052 MONZA, ITALY
[2] UNIV BARI, BARI, ITALY
关键词
CENTRAL NERVOUS SYSTEM METASTASIS; OVARIAN CARCINOMA;
D O I
10.1093/oxfordjournals.annonc.a059246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Central nervous system (CNS) involvement by ovarian carcinoma is rare. Patients and methods: From September 1982 to September 1994, 23 patients with CNS metastases from ovarian carcinoma were observed in our institution. Results: Their median age at the time of CNS metastasis diagnosis was 59 years, and the median interval between diagnosis of ovarian cancer and documentation of the metastasis was 35 months. The most common symptoms related to CNS involvement were motor weakness, headache, seizures, dizziness and visual disturbances. One patient had meningeal carcinomatosis; 22 had parenchymal lesions (18 cerebral and 4 cerebellar). Nine patients had a single CNS lesion, and 13 had multiple metastatic sites. CNS was the only site of disease in 9 patients, while 8 had concomitant extra-peritoneal dissemination. The median survival (MS) from diagnosis of cerebral metastases for the entire series was five months. Four patients were not treated (MS 3 months); 14 received radiotherapy (MS 5.5 months), and five underwent surgical resection of solitary metastases followed by radiotherapy (MS 17 months). Number of CNS lesions, extent of the disease at the time of CNS metastasis and treatment were the only factors which significantly affected survival. Conclusions: The prognosis of patients with CNS metastasis from ovarian carcinoma appears poor. However, early diagnosis followed by multimodal treatment may result in significant palliation and improve overall survival in a selected group of patients.
引用
收藏
页码:571 / 574
页数:4
相关论文
共 31 条
[1]   INVOLVEMENT OF THE CENTRAL NERVOUS-SYSTEM IN PATIENTS WITH OVARIAN-CARCINOMA [J].
BARKER, GH ;
ORLEDGE, J ;
WILTSHAW, E .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1981, 88 (07) :690-694
[2]   CEREBRAL METASTASES SECONDARY TO OVARIAN-CANCER - STILL AN UNUSUAL EVENT [J].
BRUZZONE, M ;
CAMPORA, E ;
CHIARA, S ;
GIUDICI, S ;
MERLINI, L ;
SIMONI, C ;
MAMMOLITI, S ;
RUBAGOTTI, A ;
ROSSO, R .
GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :37-40
[3]   TREATMENT OF ADVANCED OVARIAN-CANCER WITH CISPLATIN, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE - EFFECT OF TREATMENT AND INCIDENCE OF INTRACRANIAL METASTASES [J].
BUDD, GT ;
WEBSTER, KD ;
REIMER, RR ;
MARTIMBEAU, P ;
LIVINGSTON, RB .
JOURNAL OF SURGICAL ONCOLOGY, 1983, 24 (03) :192-195
[4]   COMBINATION THERAPY WITH PLATINUM AND ETOPOSIDE OF BRAIN METASTASES FROM BREAST-CARCINOMA [J].
COCCONI, G ;
LOTTICI, R ;
BISAGNI, G ;
BACCHI, M ;
TONATO, M ;
PASSALACQUA, R ;
BONI, C ;
BELSANTI, V ;
BASSI, P .
CANCER INVESTIGATION, 1990, 8 (3-4) :327-334
[5]   CEREBRAL METASTASES FROM EPITHELIAL OVARIAN-CARCINOMA TREATED WITH CARBOPLATIN [J].
COPPER, KG ;
KITCHENER, HC ;
PARKIN, DE .
GYNECOLOGIC ONCOLOGY, 1994, 55 (02) :318-323
[6]  
DAUPLAT J, 1987, CANCER, V60, P2559, DOI 10.1002/1097-0142(19871115)60:10<2559::AID-CNCR2820601035>3.0.CO
[7]  
2-7
[8]  
DAUPLAT J, 1987, CANCER-AM CANCER SOC, V60, P1561, DOI 10.1002/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO
[9]  
2-V
[10]   METASTATIC BRAIN-TUMOR FOLLOWING NEGATIVE 2ND-LOOK OPERATION FOR OVARIAN-CARCINOMA [J].
DEUTSCH, M ;
BECK, D ;
MANOR, D ;
BRANDES, J .
GYNECOLOGIC ONCOLOGY, 1987, 27 (01) :116-120